DK1244433T3 - Anvendelse af ikke-humant SHIP2-knockout-pattedyr - Google Patents

Anvendelse af ikke-humant SHIP2-knockout-pattedyr

Info

Publication number
DK1244433T3
DK1244433T3 DK00974190T DK00974190T DK1244433T3 DK 1244433 T3 DK1244433 T3 DK 1244433T3 DK 00974190 T DK00974190 T DK 00974190T DK 00974190 T DK00974190 T DK 00974190T DK 1244433 T3 DK1244433 T3 DK 1244433T3
Authority
DK
Denmark
Prior art keywords
ship2
inhibitor
human
present
knockout mammals
Prior art date
Application number
DK00974190T
Other languages
Danish (da)
English (en)
Inventor
Christophe Erneux
Stephane Schurmans
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of DK1244433T3 publication Critical patent/DK1244433T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK00974190T 1999-11-03 2000-10-31 Anvendelse af ikke-humant SHIP2-knockout-pattedyr DK1244433T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99870229A EP1097713A1 (de) 1999-11-03 1999-11-03 Inhibitoren von Inositol-Phosphatase ship-2 Moleküle

Publications (1)

Publication Number Publication Date
DK1244433T3 true DK1244433T3 (da) 2006-07-10

Family

ID=8243920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00974190T DK1244433T3 (da) 1999-11-03 2000-10-31 Anvendelse af ikke-humant SHIP2-knockout-pattedyr

Country Status (9)

Country Link
US (4) US6703215B2 (de)
EP (2) EP1097713A1 (de)
JP (1) JP2003515532A (de)
AT (1) ATE318511T1 (de)
CA (1) CA2388180C (de)
DE (1) DE60026347T2 (de)
DK (1) DK1244433T3 (de)
ES (1) ES2259293T3 (de)
WO (1) WO2001032186A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097713A1 (de) * 1999-11-03 2001-05-09 Euroscreen S.A. Inhibitoren von Inositol-Phosphatase ship-2 Moleküle
US20020165192A1 (en) * 2000-09-19 2002-11-07 Kerr William G. Control of NK cell function and survival by modulation of ship activity
US7691821B2 (en) * 2001-09-19 2010-04-06 University Of South Florida Inhibition of SHIP to enhance stem cell harvest and transplantation
WO2002024233A2 (en) * 2000-09-19 2002-03-28 University Of South Florida Control of nk cell function and survival by modulation of ship activity
US20070224124A1 (en) * 2002-09-30 2007-09-27 University Of South Florida Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
US7763592B1 (en) 2003-11-20 2010-07-27 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
US7807646B1 (en) 2003-11-20 2010-10-05 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
EP1987837A1 (de) * 2007-05-02 2008-11-05 Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus Pharmazeutische Zusammensetzung zur Erhöhung der Insulinsekretion aus Pankreas-ß-Zellen
WO2012169571A1 (ja) * 2011-06-09 2012-12-13 国立大学法人 富山大学 新規なｎ－（ピリジン－２－イル）アルカンアミド誘導体およびそれらを有効成分とするｓｈｉｐ２阻害剤
WO2017201237A1 (en) * 2016-05-18 2017-11-23 The Cleveland Clinic Foundation Pip2 as a marker for hdl function and cardiovascular disease risk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023248A (en) * 1984-10-23 1991-06-11 Perstorp Ab Method of treating diabetes with inositol triphosphate
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
US6218162B1 (en) * 1995-09-27 2001-04-17 Gerald Krystal SH2-containing inositol-phosphatase
GB9525702D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Process for activating a kinase
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
CN1478783A (zh) * 1996-09-20 2004-03-03 加利福尼亚大学董事会 肌醇多磷酸酯衍生物及其使用方法
US6025198A (en) * 1999-06-25 2000-02-15 Isis Pharmaceuticals Inc. Antisense modulation of Ship-2 expression
EP1097713A1 (de) * 1999-11-03 2001-05-09 Euroscreen S.A. Inhibitoren von Inositol-Phosphatase ship-2 Moleküle

Also Published As

Publication number Publication date
WO2001032186A2 (en) 2001-05-10
ATE318511T1 (de) 2006-03-15
US7094546B2 (en) 2006-08-22
ES2259293T3 (es) 2006-10-01
DE60026347T2 (de) 2006-12-14
CA2388180C (en) 2012-01-03
US6936452B2 (en) 2005-08-30
EP1244433B1 (de) 2006-03-01
JP2003515532A (ja) 2003-05-07
US20050183146A1 (en) 2005-08-18
EP1244433A2 (de) 2002-10-02
CA2388180A1 (en) 2001-05-10
DE60026347D1 (de) 2006-04-27
US20020106713A1 (en) 2002-08-08
US6703215B2 (en) 2004-03-09
EP1097713A1 (de) 2001-05-09
WO2001032186A3 (en) 2002-07-25
US20040203087A1 (en) 2004-10-14
US20040209342A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
TR199900408T2 (xx) �kameli 6,6-Heterobisiklik t�revler.
BG106585A (en) Kinase inhibitors as therapeutic agents
DE69713402T2 (de) Liganden des neuropeptids y
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
DK1244433T3 (da) Anvendelse af ikke-humant SHIP2-knockout-pattedyr
BR9712544A (pt) Inibidores de proteases de serina, particularmente protease ns3 do vìrus hapatite c
FR2806866B1 (fr) Telegestion d'installation de distribution de carburant
DE69622652T2 (de) Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DE69033699D1 (de) Gegenüber eigenen inhibitoren resistente t-pa mutanten
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
DE69912279D1 (de) 5-ht1f agonisten
NO992282D0 (no) Benzonaftyridiner som bronkialterapentika
FI925896A0 (fi) Belaeggningskomposition och anvaendning av denna vid foerfarande foer belaeggning av metalllindning
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
TR199801582T2 (xx) Bakteri �ld�r�c� ve mantar �ld�r�c� peptit.
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
BR9812340A (pt) Antagonistas de receptor de vitronectina
ITRM960043A0 (it) Additivo per il miglioramento della pompabilita' di composizioni cementizie
BR0015301A (pt) Recipiente para limpadores úmidos
RS50002B (sr) Eletriptan hidrobromid monohidrat
DK0941975T3 (da) Injiceringscement indeholdende korrosionshæmmere
NO20011270L (no) Tricykliske <delta>3-piperidiner som <alfa>2-antagonister
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter